Results 191 to 200 of about 44,675 (226)

Predictive factors for the efficacy of radioiodine therapy in patients with Graves' disease. [PDF]

Nucl Med Commun
Iwanaga H, Fujita N, Abe S, Ito R, Abe Y, Minamimoto R, Nishii R, Naganawa S, Kato K.   +8 more
europepmc   +1 more source

On the Prospects for African Philosophy in Australia

Australian Journal of Social Issues, EarlyView.
ABSTRACT This paper grapples with the situation of people of African descent in Australia by working through the constitution of the body of academic philosophy in the country. It contends with the parochialism of the Australian philosophical community and the prospects for the cultivation of greater pluralism. Taking African philosophy as one possible
Bryan Mukandi
wiley   +1 more source

Pediatric Graves' disease: insights into clinical characteristics and treatment outcomes. [PDF]

Arch Endocrinol Metab
Anand A, Nagarajappa VH, Palany R.
europepmc   +1 more source

Uncovering Cystic Fibrosis Carrier: Insights From a Heterozygous CFTR‐F508del Rabbit Model

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disorder frequently associated with impaired mucociliary clearance and bacterial infection. Individuals carrying a single cystic fibrosis transmembrane conductance regulator (CFTR) mutation exhibit partial CFTR dysfunction and are increasingly recognized as being at risk ...
Do‐Yeon Cho, Alexis E. McFeely, Daniel Skinner, Shaoyan Zhang, Justin Hedvat, Weslee Ping‐ay, Daniel M. Beswick, Justin H. Turner, Bradford A. Woodworth, Jie Xu   +9 more
wiley   +1 more source

Graves' disease with normal or heterogeneous 99mTc uptake: insights into the atypical scintigraphy patterns. [PDF]

Arch Endocrinol Metab
Banerjee M, Chakravarti HN, Sanyal D, Jain M, Chatterjee V, Ghosh A, Biswas D.   +6 more
europepmc   +1 more source

Construction of pathogenic Sec16a mutation mouse model using CRISPR/Cas9

Animal Models and Experimental Medicine, EarlyView.
Yaqiang Hu et al. engineered a pathogenic Sec16a mutant mouse model using CRISPR/Cas9 technology. They observed that the Sec16a mutant mice displayed diminished learning and memory capabilities, along with a limb‐clasping phenotype upon tail suspension.
Yaqiang Hu, Zhiyang Zeng, Xinyu Ming, Shuming Yin, Yuting Guan, Liangcai Gao, Dali Li   +6 more
wiley   +1 more source

Reversible splenial lesion syndrome associated with Graves' disease and hepatic dysfunction: a case report. [PDF]

Front Neurosci
He X, Lin Y, Chen J, Wu X, Lv J, Liu H, Wang X, Li M, Zhong T, Zhang Y, Weng X.   +10 more
europepmc   +1 more source

Methimazole-Induced Antithyroid Arthritis Syndrome in Graves' Disease Management: A Case Report. [PDF]

Am J Case Rep
Sun KW, Wu A.
europepmc   +1 more source

Analysis of the impact of Graves' disease on the efficacy of initial radioactive iodine therapy in patients with differentiated thyroid cancer. [PDF]

Am J Cancer Res
Wu P, Jiang H, Mao Y, Luo Z, Lei Y, Zhang Q, Zeng L.   +6 more
europepmc   +1 more source

G‐CSF for Mobilizing CD34+ Cells in Individuals With SCD: A Word of Caution

American Journal of Hematology, EarlyView.
Akshay Sharma, Allistair Abraham, Monica Bhatia, María Cancio, Sonali Chaudhury, Selim Corbacioglu, Gregory M. T. Guilcher, Ashish O. Gupta, Rabi Hanna, Matthew M. Heeney, Tami John, Lakshmanan Krishnamurti, James L. LaBelle, Hemalatha G. Rangarajan, Shalini Shenoy, Elizabeth Stenger, Crawford Strunk, Courtney D. Fitzhugh   +17 more
wiley   +1 more source